Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases
Pediatric Cardiology - United States
doi 10.1007/s00246-017-1688-4
Full Text
Open PDFAbstract
Available in full text
Date
August 5, 2017
Authors
Publisher
Springer Science and Business Media LLC